StockData

Cardinal Health vs Elevance Health

CAH and ELV side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CAH and ELV compare

Elevance Health is the larger company, worth 1.4 times as much as Cardinal Health ($93.8B against $64.9B).

On earnings, Elevance Health is cheaper: it trades at 18.5× trailing earnings, against 38.6× for Cardinal Health.

Cardinal Health grew revenue faster over the last twelve months (14.2% versus 3.6% for Elevance Health).

Elevance Health keeps more of each dollar of sales as profit, with a net margin of 2.5% compared with 0.67% at Cardinal Health.

Both pay dividends: Cardinal Health yields 0.74% and Elevance Health 1.6%.

Cardinal Health scores higher on the StockData Score (16 against 15 for Elevance Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCAHELV
Size and price
Market cap$64.9B$93.8B
Share price$279.25$433.93
Change, 1 year36.0%33.2%
Change, 5 years487%4.4%
Beta (5Y)−0.060.71
Employees64K97K
StockData Score
Total score16 (better)15
Valuation score14 (better)
Growth score4 (better)2
Performance score4 (better)3
Health score3 (better)2
Dividend score44
Valuation
P/E38.6×18.5× (better)
P/S0.3× (better)0.5×
P/B–2.1×
EV/EBITDA19.4×12.9× (better)
P/FCF14.4× (better)14.4×
PEG0.49 (better)14.68
FCF yield7.0% (better)6.9%
Fair value$197.10$487.89
Margin of safety−41.7%11.1% (better)
Growth
Revenue growth (TTM)14.2% (better)3.6%
Revenue growth, 5Y average9.4%10.3% (better)
Net income growth (TTM)9.8% (better)−7.1%
EPS growth (TTM)12.1% (better)−4.1%
EPS growth, 5Y average28.3% (better)7.0%
Profitability
Gross margin3.8%89.0% (better)
Operating margin1.0%2.7% (better)
Net margin0.67%2.5% (better)
FCF margin1.8%3.2% (better)
Return on equity–11.6%
Return on invested capital136% (better)11.0%
Financial health
Debt / equity–0.69
Net debt / EBITDA1.13 (better)−0.71
Interest coverage7.5× (better)3.8×
Current ratio0.881.47 (better)
Altman Z-score5.18 (better)3.01
Piotroski F-score66
Dividends and buybacks
Dividend yield0.74%1.6% (better)
Payout ratio28.6%29.2%
Years of dividend growth17–
Dividend growth, 5Y average1.0%–
Buyback yield2.1%2.3% (better)
Shareholder yield2.8%3.9% (better)
Ownership
Held by institutions88.7%94.3%
Held by insiders0.29%0.18%
Insider net buying, 12 months−$61.6M−$4.7M (better)
Superinvestors holding28 (better)
Short interest, % of float3.3%2.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.